Neofect Co., Ltd. (KOSDAQ:290660)
South Korea · Delayed Price · Currency is KRW
1,296.00
-42.00 (-3.14%)
At close: Mar 27, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 2.01B | - | - | - | - | | | |
| | | -1.34B | -1.09B | -3.23B | -1.37B | -4.09B | | | |
| | | 10.07B | 11.49B | 12.18B | 13.62B | 6.79B | | | |
| | | -12.38% | -5.65% | -10.54% | 100.63% | - | | | |
Rehabilitation Medical Devices | | | 15.88B | 15.80B | 14.21B | 6.38B | 9.62B | | | |
Rehabilitation Medical Devices Growth | | | 0.45% | 11.23% | 122.61% | -33.64% | 70.14% | | | |
| | | 26.61B | 26.20B | 23.16B | 18.62B | 12.31B | | | |
| | | 1.57% | 13.14% | 24.34% | 51.28% | 117.78% | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 18.97B | 19.20B | 16.71B | 13.55B | 7.94B | | | |
| | | -1.23% | 14.94% | 23.26% | 70.80% | 152.50% | | | |
| | | 3.40B | 2.53B | 1.97B | 1.21B | 559.40M | | | |
| | | 34.39% | 28.24% | 63.11% | 115.92% | 56.96% | | | |
| | | 4.25B | 4.47B | 4.48B | 3.86B | 3.82B | | | |
| | | -4.94% | -0.19% | 16.00% | 1.21% | 77.18% | | | |
| | | 26.61B | 26.20B | 23.16B | 18.62B | 12.31B | | | |
| | | 1.57% | 13.14% | 24.34% | 51.28% | 117.78% | | | |
Source: S&P Global Market Intelligence.